DETERMINANTS OF HEALTH-RELATED QUALITY OF LIFE IN POSTMENOPAUSAL WOMEN RECEIVING OR INITIATING BONE LOSS MEDICATIONS: POSSIBLE EU (R) AND POSSIBLE US (TM)